Alto Neuroscience Inc. (ANRO)
Market Closed
17 Jul, 20:00
NYSE NYSE Primary $
27. 54
+0.21
+0.7684%
$
976.31M Market Cap
- P/E Ratio
- Div Yield
777,300 Volume
- Eps
$ 27.33
Previous Close Want to track ANRO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Alto Neuroscience Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| CE Curtis Ellergodt Rothschild Investment LLC | 2,885 | $33,004 | $78,125.8 | $45,121.8 | 136.72% |
 Anthony Scaramucci SkyBridge Capital II LLC | 912,000 | $1.99M | $24.58M | $22.59M | 1,133.11% |
 Point72 Asset Management LP Point72 Asset Management LP | 503,087 | $5.67M | $13.39M | $7.72M | 136.21% |
| RWM Revisor Wealth Management LLC Revisor Wealth Management LLC | 17,130 | $385,082 | $465,079.5 | $79,997.5 | 20.77% |
| RF Rekah Franca Catalyst Funds Management Pty Ltd. | 11,400 | $256,272 | $315,210 | $58,938 | 23% |
| IM Ilko Menkov Vestal Point Capita LLP | 2.06M | $30.99M | $57.91M | $26.92M | 86.85% |
 Christopher C. Powers Farther Finance Advisors, LLC | 11 | $195.87 | $302.94 | $107.07 | 54.66% |
| AS Aryn Sands GK Wealth Management LLC | 8,565 | $226,030 | $240,719.32 | $14,689.32 | 6.5% |
